Added: Curley Clingman - Date: 18.02.2022 05:05 - Views: 32509 - Clicks: 4042
Try out PMC Labs and tell us what you think. Learn More. The talk will start with basic science topics and then focus on the pathophysiology and therapeutic potential of purinergic alling. Inflammation and cancer have a long-standing association. Until recently, it was generally thought that inflammation was a protective response, or in the worst case the epiphenomenon of body reaction to cancer with no relevant consequences. This changed dramatically following the seminal observation of Francis Balkwill that TNF-ko mice were surprisingly less prone to cancer than wt .
Thousand reports followed ever since highlighting the cancer-promoting effects of inflammation, a finding to be honest that was well known to practicing physicians. The cancer-promoting effect of inflammation was further dissected into its mechanistic components with the discovery of those cells responsible for immunosuppression within the cancer microenvironment, the myeloid-derived suppressor cells MDSCs.
Men are often oblivious of the contributions of our ancestors. The relationship between inflammation and cancer is a paradigmatic example of this. As early as Virchow had clearly suggested that there was a causal link between chronic inflammation and cancer , but we have simply forgotten this crucial observation. Now, we are still struggling to fully understand the role of inflammation in cancer progression and metastatic spreading, and try to exploit it to the benefit of the patient.
Then, Geoff Burnstock came to show us that purines have a much wider role to play in physiology and pathology than ever thought before . Investigation of the pleiotropic functions of extracellular nucleotides and their receptors, the P2 receptors revealed that they are fundamental constituents of the inflammatory as well as tumor microenvironment .
Do nucleotides support tumor growth as they support inflammation? Do they modulate responses of inflammatory cells in the tumor interstitium? And the P2 receptors? Do they participate in anti-tumor responses or rather support cancer progression? Does the tumor-bearing host benefit from P2 receptor blockade? And what we know of cancer growth in P2-KO animals? These are currently hot issues that are enormously increasing our understanding of cancer, besides of course purinergic alling.
Extracellular nucleosides and nucleotides acting at adenosine receptors ARs and P2Y receptors P2YRsrespectively, both G protein-coupled receptors GPCRsare important als to modulate biological processes in many organs and tissues. We establish structure activity relationships in both receptor families, in order to provide selective agents as pharmacological probes and potential therapeutic agents. Comparison of agonist-bound and antagonist-bound forms of the P2Y 12 R indicates unprecedented structural plasticity in the outer portions of the transmembrane domains and the extracellular loops.
Among nucleoside and nucleotide ligands, conformational constraint of the normally flexible ribose moiety by synthesis of bicyclic analogues increased the selectivity. Increased conformational rigidity of A 3 AR agonists allows the exploration of interaction of specific regions of the nucleoside analogues with the target and off-target GPCRs, such as biogenic amine receptors . Plasticity of the A 3 AR structure with respect to TM2 is proposed, based on molecular modeling, to accommodate highly rigidified ligands.
Novel fluorescent derivatives of high affinity GPCR ligands are useful tool compounds for characterization of receptors and their oligomeric assemblies [4,5]. Fluorescent probes are useful for characterization of GPCRs in living cells by flow cytometry. Fluorescent agonists but not antagonists are highly internalized consistent with receptor internalization.
Some of the numerous therapeutic concepts associated with selective modulation of ARs and P2YRs, such as selective A 3 AR agonists for treating neuropathic pain , inflammatory diseases and liver cancer , will be discussed. Hypoxia-A2-adenosinergic immunosuppression and re-direction of immune response was initially recognized to be critical and non-redundant in protecting normal tissues from excessive inflammatory damage and autoimmunity.
This pathway was also shown to protect cancerous tissues from the anti-tumor immune response. Casual Dating Voss NorthDakota 58261 power and versatility of this pathway is confirmed by other scientists and by bacteria that evolved to hijack the A2-adenosinergic immunosuppression for their own protection. Recent important studies of human tumors and pre-clinical data added to growing support to combine these co-adjuvants with cancer immunotherapies.
The discovery and medical applications of targeting the hypoxia-A2-adenosinergic pathway were made possible by earlier accomplishments of an elite group of multidisciplinary scientists who succeeded in developing the sophisticated knowledge and tools to study the role of extracellular ATP and adenosine in biological processes despite the overwhelming skepticism by the mainstream. Purines act as extracellular aling molecules in the brain and are involved in a of diverse functions, such as sleep, learning and memory, myelination and vasodilation.
The diversity of functional roles carried out by ATP, ADP and adenosine questions how cross-talk among them is minimized. While it is known that the structurally complex microenvironment of the brain forms anatomical aling niches between different cells, or cell types, less is known about the molecular composition of such aling domains in relation to purinergic aling.
Here, we performed a molecular analysis of the cell type specific pathways involved in purinergic aling, including the cellular sources of ATP, ADP and adenosine as ligands, the purine receptors sensing purines, and ecto-enzymes and transporters metabolizing purines and eliminating extracellular adenosine. Given the vast of purinergic effector molecules, we established a brain transcriptome databank from FACS-purified astrocytes, microglia, oligodendrocytes, endothelial cells and pericytes from cortical brain dissociates.
Surprisingly, we found that ecto-enzymatic Casual Dating Voss NorthDakota 58261 of adenosine are strictly compartmentalized to oligodendrocytes, and that an ATP-to-adenosine pathway is not ubiquitously present among all cell types. We propose that cross-talk among adenosine pathways is likely minimized through the combined effect of anatomical aling niches and cell type specific mosaic expression of purinergic activities therein.
For most of the enzymes that metabolize extracellular nucleotides, detailed models for the structures and catalytic mechanisms have become available in recent years . In my talk, I will first give an overview of these structures and chemical mechanisms in comparison. It catalyzes the hydrolysis of AMP and is the primary source of extracellular adenosine.
The effects of adenosine are often opposite to those of ATP and CD73 activity has an important regulatory role in processes such as inflammation, hypoxia and certain types of cancer. Homologs of CD73 exist in bacteria and other microorganisms.
These enzymes are usually monomeric and in the case of the best studied enzyme from E. A comparison of the structures suggests that a structural control of the low energy domain orientations is responsible for this substrate selectivity. Spin-label EPR studies demonstrate that the bacterial enzyme is present in the open state in the absence of ligands and a mixture of open and closed forms exists in the presence of AMPCP. Based on the structures of CD73 we aim to support rational inhibitor de by determining complex structures.
Allosteric inhibitors might be developed that block the domain motion of the enzyme. A wide range of biophysical and structural techniques can now be applied to GPCRs. Such methods can be used to de small molecules modulators with improved physicochemical properties, potency and selectivity. The first step in structure based discovery is the generation of large quantities of purified protein required for biophysical and structural studies. Heptares StaR technology is used whereby GPCRs are engineered to include a small of point mutations which greatly increase their thermostability and facilitate the purification of stable correctly folded protein capable of ligand binding and retaining the correct pharmacology.
In this talk structural features of the different classes of receptors will be compared. For Class A the adenosine A 2A receptor  will be used as an example of insights that can be derived from new ligand-receptor complexes and to illustrate a variety of computational methods, including water energetics, which are used analyse druggability and drive de.
The CRF 1 receptor  will be used as an example of a Class B receptor structure which illustrates the problems in the discovery of small molecule modulators for this class of peptide receptors. Finally we will present our recently solved Class C structure the metabotropic glutamate receptor mGlu5  which explains some of the challenges in Casual Dating Voss NorthDakota 58261 negative allosteric modulators for this receptor.
The ability of L. We observed that recombinant, refolded Lpg hydrolysed ATP only and exhibited divalent cation preference for manganese II ions. Similar to lpgan lpg mutant was impaired for replication in both human alveolar macrophages and amoebae, however, complementation with either lpg or lpg restored intracellular replication, suggesting some functional redundancy between the two enzymes.
Unlike many eukaryotic-type proteins from L. In summary, the ability of L. P2Y receptors P2YRs have established roles in the cardiovascular, nervous, respiratory and immune systems . Moreover, accumulating evidence suggests that the coordinated action of multiple P2YRs crucially orchestrates both acute remodelling events after tissue injury and the subsequent repair and regeneration. Some P2YRs indeed act as sensors of phagocytosis and participate to clearance of dying cells and debris after damage e.
Moreover, several other P2YRs e. Globally, these findings open up new perspectives in the exploitment of P2YRs for new regenerative therapies.
In this respect, GPR17 has recently emerged as a new target for demyelinating disorders. GPR17 is closely related to P2Y and CysLT receptors [7,8] and can be activated by both uracil nucleotides and cysteinyl-leukotrienes, as well as by new synthetic ligands [9,10]. Under physiological conditions, GPR17 is transiently expressed by oligodendrocyte precursor cells OPCs in transition to pre-immature oligodendrocytes and markedly downregulated in mature myelinating cells [11,12].
In vivoincreased levels of GPR17 at the site of brain Casual Dating Voss NorthDakota 58261, indicate a role in post-damage events [13,14]. Targeted inhibition of GPR17 markedly affected OPC differentiation in vitro, suggesting a potential role in myelin repair  see also Abbracchio et al.
In silico modeling and virtual screening, followed by functional and pharmacological in vitro confirmation have identified additional GPR17 ligands  that may represent prototypic molecules for new regenerative medicine therapies. We started our drug discovery efforts for a novel pharmacological stress agent to replace adenosine Ado with the hypothesis that a short acting functionally selective A 2A adenosine receptor agonist would have fewer side effects.
It was known at the onset of the program that an appropriately 2-substituted adenosine analog  could impart selectivity for A 2A AdoR selectivity over A 1 AdoR, so we deed series exemplified by acetylene 1and N-pyrazole 2 regadenoson. Critical to the success of our program was the choice of measuring the vasodilatation induced by our A 2A AdoR agonist in an isolated heart model rat attempting to match the duration of effect of adenosine .
The acetylene 1 had too long of a vasodilatory effect 23 min that was attributed to the high affinity for the A 2A AdoR. Regadenoson 2 had a modest duration of effect 11 min more closely matching the duration of effect of adenosine 8 minand a modest A 2A AdoR affinity 1.
Regadenoson is 10 fold selective over A 1 AdoR binding affinity, but more than fold functionally selective for coronary vasodilation over A 1 AdoR mediated negative dromotropic effects, and highly selective over peripheral vasodilatory effects hypotension.
The latter tissue selectivity may be due to the partial A 2A AdoR agonism cAMPand the high receptor reserve of the coronary arterial circulation, hence requiring only a smaller percentage of A 2A AdoR occupancy to cause near-maximal vasodilatation. There are several options for new cardiovascular therapies involving adenosine A1 receptor activation in e. The main issue of using A1 receptor agonists in therapies is the broad spectrum of physiological A1 effects. Desired cardiovascular effects such as cardioprotection can be counter-regulated by undesired ones like pronounced bradycardia AV-block or decreased glomerular filtration rate and diuresis.
This restriction for the use of A1 receptor agonists as therapeutic target can be overcome by tailoring compounds only to the desired pharmacological efficacy by the development of partial adenosine A1 receptor agonists. There are now several partial A1 agonists Casual Dating Voss NorthDakota 58261 in the literature like GS and VCP with different degrees of partiality and resulting pharmacological activity. Bayer has identified the first non-adenosine like partial A1 agonists like Capadenoson which are suitable for an oral once daily treatment of patients. Capadenoson has an EC 50 of 0. A2a, vs.
A2b and no activity on A3 receptors . In consistency with the predicted pharmacological effects of a partial A1 receptor agonist, Capadenoson showed reduced bradycardic effects and no AV block. In preclinical models of acute myocardial infarction and heart failure the partial A1 agonist reduced infarct size and ificantly improved heart function [1,2].
In clinical studies the compound did not reduce heart rate at rest in healthy subjects or patients with stable angina pectoris, but reduced heart rate at peak exercise compared with placebo . A single dose of Capadenoson resulted in a ificant increase of exercise time.Casual Dating Voss NorthDakota 58261
email: [email protected] - phone:(214) 928-6900 x 3478
Abstracts from Purines , an International Conference on Nucleotides, Nucleosides and Nucleobases, held in Bonn, Germany, from July 23–27,